Company
Rebus Holdings, Inc. (0001421204)
Standardized SEC financial data for Rebus Holdings, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001421204 · Pharmaceutical Preparations.
Income statement
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| R&D expense | $1.7M | $208K | $44K | $18K | $494K | $239K |
| SG&A expense | $1.7M | $516K | $565K | $494K | $528K | $425K |
| Operating income | -$5.9M | -$724K |
Standardized from Rebus Holdings, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10K | $331K | $23K | $404K | $711K | $5K |
| Total current assets |
Cash flow
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$1.1M | -$204K | -$313K | -$374K | -$693K | -$706K |
| Capital expenditures |
Get 0001421204 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001421204/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001421204/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"